Medical Devices: Page 11
-
Owens & Minor inks $375M deal to sell unit to investment firm
The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that provides products directly to patients.
By Nick Paul Taylor • Oct. 8, 2025 -
AdvaMed CEO: ‘Just give us some certainty’
At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the government shutdown.
By Elise Reuter • Oct. 8, 2025 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
How 4 medtech CEOs are using AI
At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use the technology internally is challenging.
By Elise Reuter • Oct. 7, 2025 -
Convatec plans $1B investment in R&D in the US and UK
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.
By Nick Paul Taylor • Oct. 7, 2025 -
Sponsored by Arena
How AI-driven supply chain intelligence is transforming medical device manufacturing
AI-powered supply chain intelligence helps MedTech firms overcome EOL risks and regulatory hurdles.
Oct. 6, 2025 -
Q&A
Hospital for Special Surgery’s Ashis Barad says AI must solve real problems
Barad, chief digital and technology officer at HSS, outlined his approach to evaluating AI tools and how the orthopedic hospital uses the technology.
By Elise Reuter • Oct. 3, 2025 -
Medtronic wins CE mark for Penditure LAA exclusion device
The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
By Nick Paul Taylor • Oct. 3, 2025 -
CDRH shares regulatory guidance priorities for the coming 12 months
Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.
By Nick Paul Taylor • Oct. 2, 2025 -
SS Innovations changes course on FDA filing for soft tissue robot
A 510(k) submission now planned for this quarter sets up a potentially faster clearance than the de novo pathway originally planned, the company said.
By Susan Kelly • Oct. 2, 2025 -
Boston Scientific aims for market leadership in electrophysiology
The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.
By Elise Reuter • Oct. 2, 2025 -
Distalmotion adds hysterectomy indication; AiM raises funds for neurosurgical robot
The clearance gives Distalmotion, which sees opportunity in ambulatory settings, a third robotic procedure category in the U.S. Elsewhere, AiM Medical Robotics raised $8.1 million.
By Susan Kelly • Oct. 2, 2025 -
FDA seeks feedback on monitoring real-world performance of AI devices
The agency is looking for ways to detect, assess and mitigate changes to the performance of AI-enabled devices over time.
By Nick Paul Taylor • Oct. 1, 2025 -
Boston Scientific unveils plans for new Watchman device
The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.
By Elise Reuter • Updated Oct. 14, 2025 -
Top medtech conferences in 2026
The medical device industry has a jam-packed year of events for professionals to attend, including the J.P. Morgan Healthcare Conference, DeviceTalks Boston and AdvaMed’s annual medtech meeting.
By Ricky Zipp • Updated Jan. 28, 2026 -
FDA expands early alert program to cover all medical devices
After a successful pilot, the agency has lifted the limitations on when it will provide early information about potentially high-risk safety events.
By Nick Paul Taylor • Sept. 30, 2025 -
Medtech firms splitting into ‘haves’ and ‘have-nots’: EY
The number of medtech funding rounds has declined in recent months, but the value of overall deals has increased, according to a new report from EY.
By Elise Reuter • Sept. 29, 2025 -
EssilorLuxottica wins FDA OK for myopia-slowing eyeglass lenses
Investigators saw a 71% reduction in myopia progression in children who used the lenses for two years.
By Nick Paul Taylor • Sept. 29, 2025 -
Biolinq gets FDA de novo nod for intradermal glucose sensor
The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.
By Elise Reuter • Updated Sept. 29, 2025 -
SS Innovations hires new CFO
Naveen Kumar Amar joins the surgical robot developer as it prepares to expand globally, including in Europe and the U.S.
By Susan Kelly • Sept. 26, 2025 -
MedTech Europe pressures EU to make regulatory changes by early 2026
The request includes a call to postpone re-certification requirements for devices already certified under the medical technology regulations.
By Nick Paul Taylor • Sept. 26, 2025 -
Section 232 probe reignites tariff uncertainty for medtech firms
The Trump administration has used the investigations in other sectors to implement tariffs, but the earliest any potential actions would take place is summer 2026, analysts said.
By Elise Reuter • Sept. 26, 2025 -
Heartflow receives FDA clearance for updated plaque analysis platform
The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.
By Nick Paul Taylor • Sept. 25, 2025 -
US opens investigation into medical equipment, device imports
As part of the Section 232 probe, the Trump administration will weigh the need for tariffs on goods such as surgical masks, blood glucose monitors and wheelchairs.
By Phil Neuffer • Sept. 25, 2025 -
Q&A
Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership
Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in becoming a standalone firm.
By Elise Reuter • Sept. 25, 2025 -
Medtronic expands AI, robotics hub in London; Virtuoso robot gets FDA breakthrough status
The Medtronic center will facilitate surgeon collaboration and AI-powered decision support. At Virtuoso Surgical, a robotic approach to bladder lesion removal is expected to improve precision.
By Susan Kelly • Sept. 24, 2025